oxycontin

Cost-effectiveness of extended buprenorphine–naloxone treatment for opioid-dependent youth: data from a randomized trial

by Dr. Rich on September 5, 2011

Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers

by Dr. Rich on September 5, 2011

Factors associated with complicated buprenorphine inductions

by Dr. Rich on September 5, 2011

Office-Based Treatment Effective for Opioid Dependence

by Dr. Rich on September 5, 2011

Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program: A Randomized Trial.

by Dr. Rich on September 5, 2011

Opioid-Dependent Patients Respond to Therapy

by Dr. Rich on September 5, 2011

Office-Based Opioid Treatment Keeps Ex-Inmates Out of Jail

by Dr. Rich on September 5, 2011

Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile

by Dr. Rich on September 5, 2011

FDA Approves Sublingual Film Formulation of Buprenorphine/Naloxone

by Dr. Rich on September 5, 2011

Opioid Dependence Drug Gets Okay for New Delivery Mode

by Dr. Rich on September 5, 2011

← Previous Entries

Next Entries →